These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38434042)

  • 1. Disrupted nuclear import of cell cycle proteins in Huntington's/PolyQ disease causes neurodevelopment defects in cellular and Drosophila model.
    Dubey SK; Lloyd TE; Tapadia MG
    Heliyon; 2024 Feb; 10(4):e26393. PubMed ID: 38434042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant Huntingtin Disrupts the Nuclear Pore Complex.
    Grima JC; Daigle JG; Arbez N; Cunningham KC; Zhang K; Ochaba J; Geater C; Morozko E; Stocksdale J; Glatzer JC; Pham JT; Ahmed I; Peng Q; Wadhwa H; Pletnikova O; Troncoso JC; Duan W; Snyder SH; Ranum LPW; Thompson LM; Lloyd TE; Ross CA; Rothstein JD
    Neuron; 2017 Apr; 94(1):93-107.e6. PubMed ID: 28384479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbations in Traffic: Aberrant Nucleocytoplasmic Transport at the Heart of Neurodegeneration.
    Fahrenkrog B; Harel A
    Cells; 2018 Nov; 7(12):. PubMed ID: 30486313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.
    Gunawardena S; Her LS; Brusch RG; Laymon RA; Niesman IR; Gordesky-Gold B; Sintasath L; Bonini NM; Goldstein LS
    Neuron; 2003 Sep; 40(1):25-40. PubMed ID: 14527431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
    Preisinger E; Jordan BM; Kazantsev A; Housman D
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntingtin aggregation and toxicity in Huntington's disease.
    Bates G
    Lancet; 2003 May; 361(9369):1642-4. PubMed ID: 12747895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA; Mann DM
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the ribosomal quality control machinery in nucleocytoplasmic translocation of polyQ-expanded huntingtin exon-1.
    Zheng J; Yang J; Choe YJ; Hao X; Cao X; Zhao Q; Zhang Y; Franssens V; Hartl FU; Nyström T; Winderickx J; Liu B
    Biochem Biophys Res Commun; 2017 Nov; 493(1):708-717. PubMed ID: 28864412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.
    Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E
    Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.
    Liu KY; Shyu YC; Barbaro BA; Lin YT; Chern Y; Thompson LM; James Shen CK; Marsh JL
    Hum Mol Genet; 2015 Mar; 24(6):1602-16. PubMed ID: 25398943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Huntingtin Is Secreted via a Late Endosomal/Lysosomal Unconventional Secretory Pathway.
    Trajkovic K; Jeong H; Krainc D
    J Neurosci; 2017 Sep; 37(37):9000-9012. PubMed ID: 28821645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic effects of mutant huntingtin in axons are mediated by its proline-rich domain.
    Brady ST; Mesnard-Hoaglin NA; Mays S; Priego M; Dziechciowska J; Morris S; Kang M; Tsai MY; Purks JL; Klein A; Gaona A; Melloni A; Connors T; Hyman B; Song Y; Morfini GA
    Brain; 2024 Jun; 147(6):2098-2113. PubMed ID: 37633260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.
    Subramaniam S
    J Huntingtons Dis; 2022; 11(3):281-290. PubMed ID: 35871361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.
    Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K
    PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
    Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R
    Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsc70-4 aggravates PolyQ-mediated neurodegeneration by modulating NF-κB mediated immune response in
    Rai S; Tapadia MG
    Front Mol Neurosci; 2022; 15():857257. PubMed ID: 36425218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
    Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
    Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.